Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Comparison of calculated dose distributions reported as dose-to-water and dose-to-medium for intensity-modulated radiotherapy of nasopharyngeal cancer patients.

Radojčić ÐS, Kolacio MŠ, Radojčić M, Rajlić D, Casar B, Faj D, Jurković S.

Med Dosim. 2018 Jan 4. pii: S0958-3947(17)30135-8. doi: 10.1016/j.meddos.2017.11.008. [Epub ahead of print]

PMID:
29306538
2.

Influence of the Integral Quality Monitor transmission detector on high energy photon beams: A multi-centre study.

Casar B, Pasler M, Wegener S, Hoffman D, Talamonti C, Qian J, Mendez I, Brojan D, Perrin B, Kusters M, Canters R, Pallotta S, Peterlin P.

Z Med Phys. 2017 Sep;27(3):232-242. doi: 10.1016/j.zemedi.2016.10.001. Epub 2017 Mar 21.

PMID:
28336006
3.

Analysis of Ras/ERK Compartmentalization by Subcellular Fractionation.

Agudo-Ibañez L, Crespo P, Casar B.

Methods Mol Biol. 2017;1487:151-162.

PMID:
27924565
4.

Grid patterns, spatial inter-scan variations and scanning reading repeatability in radiochromic film dosimetry.

Méndez I, Šljivić Ž, Hudej R, Jenko A, Casar B.

Phys Med. 2016 Sep;32(9):1072-81. doi: 10.1016/j.ejmp.2016.08.003. Epub 2016 Aug 9.

PMID:
27520403
5.

ERK Signals: Scaffolding Scaffolds?

Casar B, Crespo P.

Front Cell Dev Biol. 2016 May 31;4:49. doi: 10.3389/fcell.2016.00049. eCollection 2016.

6.

Defined spatiotemporal features of RAS-ERK signals dictate cell fate in MCF-7 mammary epithelial cells.

Herrero A, Casar B, Colón-Bolea P, Agudo-Ibáñez L, Crespo P.

Mol Biol Cell. 2016 Jun 15;27(12):1958-68. doi: 10.1091/mbc.E15-02-0118. Epub 2016 Apr 20.

7.

Medical physics in Europe following recommendations of the International Atomic Energy Agency.

Casar B, Lopes Mdo C, Drljević A, Gershkevitsh E, Pesznyak C.

Radiol Oncol. 2016 Feb 16;50(1):64-72. doi: 10.1515/raon-2016-0004. eCollection 2016 Mar 1. Review.

8.

Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes.

Herrero A, Pinto A, Colón-Bolea P, Casar B, Jones M, Agudo-Ibáñez L, Vidal R, Tenbaum SP, Nuciforo P, Valdizán EM, Horvath Z, Orfi L, Pineda-Lucena A, Bony E, Keri G, Rivas G, Pazos A, Gozalbes R, Palmer HG, Hurlstone A, Crespo P.

Cancer Cell. 2015 Aug 10;28(2):170-82. doi: 10.1016/j.ccell.2015.07.001.

9.

On multichannel film dosimetry with channel-independent perturbations.

Méndez I, Peterlin P, Hudej R, Strojnik A, Casar B.

Med Phys. 2014 Jan;41(1):011705. doi: 10.1118/1.4845095.

PMID:
24387497
10.

Gafchromic EBT2 film dosimetry in reflection mode with a novel plan-based calibration method.

Mendez I, Hartman V, Hudej R, Strojnik A, Casar B.

Med Phys. 2013 Jan;40(1):011720. doi: 10.1118/1.4772075.

PMID:
23298090
11.

In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI.

Oncogene. 2014 Jan 9;33(2):255-68. doi: 10.1038/onc.2012.547. Epub 2012 Dec 3.

12.

Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.

Casar B, He Y, Iconomou M, Hooper JD, Quigley JP, Deryugina EI.

Oncogene. 2012 Aug 30;31(35):3924-38. doi: 10.1038/onc.2011.555. Epub 2011 Dec 19.

13.

Mxi2 sustains ERK1/2 phosphorylation in the nucleus by preventing ERK1/2 binding to phosphatases.

Casar B, Rodríguez J, Gibor G, Seger R, Crespo P.

Biochem J. 2012 Jan 15;441(2):571-8. doi: 10.1042/BJ20110870.

PMID:
21950314
14.

ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes.

Rodríguez J, Calvo F, González JM, Casar B, Andrés V, Crespo P.

J Cell Biol. 2010 Nov 29;191(5):967-79. doi: 10.1083/jcb.201004067. Erratum in: J Cell Biol. 2011 Jan 10;192(1):201.

15.

ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task.

Casar B, Pinto A, Crespo P.

Cell Cycle. 2009 Apr 1;8(7):1007-13. Epub 2009 Apr 4.

PMID:
19279408
16.

Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins.

Casar B, Arozarena I, Sanz-Moreno V, Pinto A, Agudo-Ibáñez L, Marais R, Lewis RE, Berciano MT, Crespo P.

Mol Cell Biol. 2009 Mar;29(5):1338-53. doi: 10.1128/MCB.01359-08. Epub 2008 Dec 29.

17.

Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope.

González JM, Navarro-Puche A, Casar B, Crespo P, Andrés V.

J Cell Biol. 2008 Nov 17;183(4):653-66. doi: 10.1083/jcb.200805049.

18.

Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes.

Casar B, Pinto A, Crespo P.

Mol Cell. 2008 Sep 5;31(5):708-21. doi: 10.1016/j.molcel.2008.07.024.

19.

Mxi2 promotes stimulus-independent ERK nuclear translocation.

Casar B, Sanz-Moreno V, Yazicioglu MN, Rodríguez J, Berciano MT, Lafarga M, Cobb MH, Crespo P.

EMBO J. 2007 Feb 7;26(3):635-46. Epub 2007 Jan 25.

Supplemental Content

Support Center